Optimal anatomic coverage for CT in staging lung cancer: lessons from PET-CT correlation
- PMID: 21094559
- DOI: 10.1016/j.lungcan.2010.10.021
Optimal anatomic coverage for CT in staging lung cancer: lessons from PET-CT correlation
Abstract
Objective: To determine the optimal anatomic coverage at CT that would provide the most accurate staging for patients with non-small cell lung cancer.
Methods: We reviewed lung cancer staging PET-CT scans and correlated them with staging chest CT scans performed within 50 days of the PET-CT study. There were 113 patients who underwent both studies within our time frame. We reviewed the results of subsequent imaging studies and surgical and biopsy procedures to determine the final stage for each patient. This study was approved by the local institutional review board.
Results: In 86 (76%) of 113 patients, staging by PET-CT and by CT from the lung apices through the lung bases was identical. PET-CT upstaged 21 patients (19%) compared with CT findings; in 13 of these patients the PET-CT noted disease that was either outside of the anatomic range of any lung cancer staging CT or was within the area scanned by CT, but was not evident by CT. In the other 8 upstaged patients, extending the anatomic scope of the CT scan to the supraclavicular region (5), adrenal glands (2) or abdomen (1) would have resulted in correct staging.
Conclusions: CT scanning from the supraclavicular region through the caudal adrenal glands improves the accuracy of CT staging of lung cancer compared with scanning from the lung apices through the lung bases. Anatomic coverage beyond the adrenal glands has a low yield for improved staging, at the cost of requiring administration of oral contrast to all patients.
Summary: To determine the optimal anatomic coverage at CT that would provide the most accurate staging for patients with non-small cell lung cancer, we reviewed lung cancer staging PET-CT scans and correlated them with staging chest CT scans performed within 50 days of the PET-CT study. CT scanning from the supraclavicular region through the caudal adrenal glands improves the accuracy of CT staging of lung cancer compared with scanning from the lung apices through the lung bases. Anatomic coverage beyond the adrenal glands has a low yield for improved staging, at the cost of requiring administration of oral contrast to all patients undergoing lung cancer staging.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Characteristics of advantages of positron emission tomography over computed tomography for N-staging in lung cancer patients.Jpn J Clin Oncol. 2006 Nov;36(11):694-8. doi: 10.1093/jjco/hyl092. Epub 2006 Oct 26. Jpn J Clin Oncol. 2006. PMID: 17068084
-
Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.N Engl J Med. 2003 Jun 19;348(25):2500-7. doi: 10.1056/NEJMoa022136. N Engl J Med. 2003. PMID: 12815135
-
Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.Eur J Cardiothorac Surg. 2009 Sep;36(3):440-5. doi: 10.1016/j.ejcts.2009.04.003. Epub 2009 May 22. Eur J Cardiothorac Surg. 2009. PMID: 19464906 Review.
-
[Comparing serum tumor antigen detection combined with CT scan with PET-CT for lung cancer diagnosis].Ai Zheng. 2006 Jan;25(1):66-8. Ai Zheng. 2006. PMID: 16405752 Chinese.
-
Integrated PET/CT in the staging of nonsmall cell lung cancer: technical aspects and clinical integration.Eur Respir J. 2009 Jan;33(1):201-12. doi: 10.1183/09031936.00035108. Eur Respir J. 2009. PMID: 19118231 Review.
Cited by
-
Multidisciplinary consensus statement on the clinical management of patients with stage III non-small cell lung cancer.Clin Transl Oncol. 2020 Jan;22(1):21-36. doi: 10.1007/s12094-019-02134-7. Epub 2019 Jun 6. Clin Transl Oncol. 2020. PMID: 31172444
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical